CSL (ASX:CSL) — Material Events
ASX:CSL · 14 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
CSL Unveils $500m Cost-Cutting Plan and CSL Seqirus Demerger in FY25 ResultsHigh
CSL posts strong FY25 results, announces CSL Seqirus demerger and $500m cost savings
19 Aug 2025
·Results Presentation
·90
CSL Unveils Bold Transformation with $500m Cost Cuts and Seqirus DemergerHigh
CSL reports strong FY25 results, announces CSL Seqirus demerger and $500m cost savings
19 Aug 2025
·Full Year Financial Results and Strategic Update
·90
CSL Reports 14% Profit Surge, Eyes Seqirus Demerger Amid Sustainability DriveHigh
CSL Limited reports 14% NPAT growth, plans Seqirus demerger, and advances sustainability goals
19 Aug 2025
·Annual Results and Corporate Governance Report
·90
CSL Cuts FY26 Revenue Forecast, Flags $5 Billion Asset ImpairmentsHigh
CSL revises FY26 guidance down, announces $5 billion impairments, leadership changes
11 May 2026
·Interim CEO Review and Financial Update
·Unexpected
·85
CSL’s $1.9b NPATA Dip Masks Ambitious Growth and $750m Buy-Back BoostHigh
CSL reports 7% underlying NPATA decline, maintains FY26 guidance amid transformation and $750m buy-back
11 Feb 2026
·Half Year Financial Report
·85
CSL Reports $8.3B Revenue, Advances Transformation, Maintains FY26 OutlookMedium
CSL Limited reports 1H26 results with $8.3B revenue, strong transformation progress, maintains FY26 guidance, expands share buyback
11 Feb 2026
·Results Presentation
·85
CSL Delays Seqirus Demerger, Targets $500M Cost Savings Amid Market HeadwindsHigh
CSL revises FY26 outlook down, delays Seqirus demerger, targets $500m cost savings by FY28
28 Oct 2025
·Annual General Meeting Presentation
·Unexpected
·85
CSL’s Profit Plummets 80% Amid $2 Billion Restructuring and ImpairmentsHigh
CSL reports 80% profit drop due to $2.06B impairments, maintains growth guidance and dividends
11 Feb 2026
·Results Announcement
·Unexpected
·85
CSL CEO Paul McKenzie Retires; Gordon Naylor Steps In as Interim LeaderMedium
CSL CEO Paul McKenzie retires; Gordon Naylor named interim CEO
10 Feb 2026
·Executive Leadership Change
·75
CSL Seqirus Poised for Growth as US Influenza Market RecoversMedium
CSL Limited outlines growth strategy for CSL Seqirus influenza vaccines at Capital Markets Day
5 Nov 2025
·Capital Markets Day Presentation
·70
CSL Declares USD 1.62 Dividend Amid Currency Payment NuancesMedium
CSL Limited declares USD 1.62 unfranked dividend for H1 2025
19 Aug 2025
·Notification of dividend / distribution
·60
CSL Declares USD 1.30 Unfranked Dividend for H2 2025Medium
CSL declares USD 1.30 unfranked dividend payable April 2026
11 Feb 2026
·Dividend/Distribution Announcement
·60
No articles in this tier for the last 12 months.
Market Mentions
3
- appeared in market wrap coverage
These are market wrap articles where CSL (ASX:CSL) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 20 (11 May -> 15 May) 2026
16 May 2026
Market Wrap - Week 7 (9 Feb -> 13 Feb) 2026
14 Feb 2026
Healthcare Wrap - Week 7 (9 Feb -> 13 Feb) 2026
14 Feb 2026